<DOC>
	<DOCNO>NCT02026778</DOCNO>
	<brief_summary>Many patient undergo gynecologic laparoscopic surgery experience postoperative nausea vomiting ( PONV ) despite prophylaxis treatment HT3 receptor antagonists ondansetron . Involvement multiple type receptor factor may reason inadequate control PONV single agent . Betahistine , histamine antagonist H1 receptor antagonist H3 receptor , widely use treatment dizziness . Dizziness one cause nausea vomit . This study compare effect ondansetron combine ondansetron betahistine prevent PONV high-risk patient receive intravenous opioid-based patient-controlled analgesia ( IV-PCA ) gynecological laparoscopic surgery .</brief_summary>
	<brief_title>Comparison Effect Ondansetron Combined Ondansetron Betahistine Postoperative Nausea Vomiting After Gynecological Laparoscopy</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Betahistine</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Patient schedule elective gynecological laparoscopic surgery American society Anesthesiologists physical class I , â…¡ , age 20 70 year hepatorenal disease BMI &gt; 35 kg/m2 allergy ondansetron betahistine gastrointestinal disease vomit within 24h administration antiemetic opioids within 24h QT prolongation ( QTc &gt; 440ms ) Pheochromocytoma pregnant problem communication</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>